Security key
758338404
REED'S, INC. - Common Stock, par value $0.0001 per share (REED)
CUSIP: 758338404
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 771,490
- Total 13F value
- $2,799,920
- Share change
- -1,755
- SEC-reported price per share
- $3.63
- Number of holders
- 17
- Value change
- +$36,098
- Number of buys
- 8
- Number of sells
- 7
- Shares outstanding
- 11,893,587
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
17
Top holders
10
REED full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
REED'S, INC. SEC filings
REED'S, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 758338404
Recent filing periods:
Ownership snapshot
Top reported holders of REED - REED'S, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Shufen Deng
Disclosed value leader
Era Regenerative Medicine...
Comparable rows
15/15
Latest evidence
05 Jan 2026
13D/G
3/4/5
13F
Lead comparable stake: 60%
13D/G row: Shufen Deng
Showing 1-6 of 15 holder rows.
Quick read
Shufen Deng leads the comparable SEC ownership view at 60%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Shufen Deng's linked filing trail.
Comparable ownership
Top 5
Shufen Deng
60%
Era Regenerative Medicine Ltd
58%
WHITEBOX ADVISORS LLC
0.8%
Neal Cohane
0%
ARMISTICE CAPITAL, LLC
5.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Shufen Deng |
13D/G
3/4/5
D&D Source of Life Holding Ltd. · Director
|
60%
|
$51,022,296
27,139,519 shares
|
$0 | 30 Dec 2024 |
| Era Regenerative Medicine Ltd |
13D/G
3/4/5
10%+ Owner
|
58%
|
$53,043,803
28,214,789 shares
|
+$2,021,506 | 04 Jun 2025 |
| WHITEBOX ADVISORS LLC |
13D/G
|
0.8%
|
$484,557
257,743 shares
|
$0 | 31 Dec 2024 |
| Neal Cohane |
3/4/5
Chief Operating Officer
|
0%
|
$675
675 shares
|
— | 05 Jan 2026 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
5.2%
|
$1,302,000
620,000 shares
|
— | 31 Dec 2025 |
| JANE STREET GROUP, LLC |
13F
Company
|
0.13%
|
$31,771
15,129 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
17
Shares
771,490
Rows available
17
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
14
Q1 2026 holders
17
Holder diff
3
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend